Uterine cancer, including endometrial cancer that affects the lining of the uterus, is often highly treatable when detected early. Certain factors can increase risk, such as hormonal imbalances, obesity, prior estrogen or tamoxifen use, pelvic radiation history, family history of uterine cancer, and never having been pregnant. Because early-stage uterine cancer frequently presents with noticeable symptoms, prompt evaluation and appropriate testing play a critical role in achieving positive outcomes.
Abnormal vaginal bleeding, pelvic pain, discomfort during urination, or pain during intercourse are symptoms that should never be ignored. When these warning signs are attributed to benign conditions without proper investigation, valuable time may be lost. Delays in diagnosis can allow uterine cancer to progress, limiting treatment options and worsening prognosis, even though early detection often leads to very high survival rates.
When uterine or endometrial cancer is suspected, providers have access to several diagnostic tools that can help confirm or rule out cancer. These may include pelvic examinations, ultrasound imaging, MRI studies, and biopsies of uterine or endometrial tissue. If cancer is detected, additional testing is typically performed to determine whether the disease has spread and to guide treatment decisions.
Uterine cancer misdiagnosis or delayed diagnosis often results from failures in evaluation and follow-up, including:
Treatment for uterine cancer often depends on how advanced the disease is at the time of diagnosis. Early-stage cancer may be treated effectively with surgery alone, while later-stage disease may require more extensive surgery, chemotherapy, radiation, or hormone therapy. As cancer progresses, treatment becomes more invasive and recovery more difficult.
What to Expect
VIEW
( 01 )